Harvest One continues its international expansion with a sales and distribution agreement for Dream Water(TM) and LivRelief(TM) products in Africa
Vancouver, British Columbia–(Newsfile Corp. – March 10, 2022) – Harvest One Cannabis Inc. (TSXV:HVT) (OTCQB:HRVOF) (“Collect one” or the “Company”), a CPG leader uniquely positioned in both the OTC and cannabis space with a focus on non-infused and cannabis-infused health and wellness products, today announced that its subsidiaries DreamWater MT and LivRelief MT signed a sales and distribution agreement (the “OK“) with the main distributor Pharmtick Limited (“Pharmacy“), based in Nigeria, Africa, to further expand their international distribution networks. Under the agreement, Pharmtick will sell and distribute DreamWater MT and LivRelief MT produced throughout Africa, for a period of three years.
“Aligning our core brands with one of Africa’s leading healthcare and wellness distributors is an important step in the continued advancement of Harvest One’s international distribution strategy,” said Gord Davey. , President and CEO of Harvest One. “Global expansion is a key priority for Harvest One. Our online sales in North America have significantly increased and expanded the reach of our brands. Access to other international markets, such as Africa, is a step important for Harvest One. Pharmtick has access to online distribution in several important countries in Africa and we strongly believe that Pharmtick is the right partner to lead our marketing and product awareness efforts on a new continent.”
Pharmtick is a leading African consumer goods distributor representing leading brands such as Pfizer, Bayer, GlaxoSmithKline, Novartis, TEVA, Actavis, Accord and Vitabiotics. Pharmtick offers a growing number of leading over-the-counter products, including products for colds, flu, allergies, heartburn and immune boosters.
For more information about Pharmtick, please visit their website at: www.pharmtick.com
About Harvest One
Harvest One is a global leader in cannabis-infused and non-infused CPGs that develops and distributes premium health, wellness and self-care products with a focus on the insomnia and pain solutions market, leading to a reduction in fatigue and anxiety. Harvest One is a uniquely positioned cannabis company that markets both cannabis-infused and non-cannabis-infused products. Harvest One has established an impressive track record of product innovation, branding, marketing and distribution through its portfolio of CPG brands. Harvest One owns and operates two subsidiaries; DreamWaterMT and LivReliefMT. For more information, visit www.harvestone.com.
Caution Regarding Forward-Looking Statements
This press release contains “forward-looking information” and “forward-looking statements” (collectively, “forward-looking statements”) within the meaning of applicable Canadian securities laws. All statements, other than statements of historical facts, are forward-looking statements and are based on expectations, estimates and projections as of the date of this press release. Any statement involving discussion of predictions, expectations, beliefs, plans, projections, goals, assumptions, future events or performance (often, but not always, using phrases such as “expects “, or “does not expect”, “is expected”, “anticipates” or “does not anticipate”, “plans”, “budgets”, “expects”, “expects”, “estimates”, “believes ” or “intends” or variations of these words and expressions or indicating that certain actions, events or results “might” or “may”, “will”, “could” or “will” be expected to occur or be achieved ) are not statements of historical fact and may be forward-looking statements. In this press release, forward-looking statements include, among others, statements regarding the extent of the Company’s product expansion in Africa, the continued success of the Company’s international distribution strategy, global expansion being a key priority for the Company, the growth of the Company’s e-commerce sales in the future, additional access to international markets, the success of the transactions contemplated under the Agreement, the future increase in revenues and the the Company’s enduring success, and the Company’s future expansion plans, initiatives and strategies .
These forward-looking statements are based on reasonable assumptions and estimates made by the management of the Company at the time such statements were made. Actual future results may differ materially because forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from the results, performance or achievements future expressed or implied by such forward-looking statements. These factors include, among others: the implications of the COVID-19 pandemic on the Company’s operations; fluctuations in general macroeconomic conditions; fluctuations in the securities markets; expectations regarding the size of the cannabis markets in which the Company operates; changing consumer habits; the Company’s ability to successfully achieve its business objectives; expansion plans; political and social uncertainties; failure to obtain adequate insurance to cover risks and hazards; employee relations and the presence of laws and regulations that may impose restrictions on the cultivation, production, distribution and sale of cannabis and cannabis-related products in the markets in which the Company operates. Although the forward-looking statements contained in this press release are based on what management of the Company believes, or believed at the time, to be reasonable assumptions, the Company cannot assure shareholders that actual results will be consistent with such statements. forward-looking statements, as there may be other factors that cause results not to be as anticipated, estimated or intended. Readers should not place undue reliance on the forward-looking statements and information contained in this press release. The Company undertakes no obligation to update any forward-looking statements of beliefs, opinions, projections or other factors should they change, except as required by law.
Additional information regarding this risk and other risks and uncertainties relating to the Company’s business can be found under the heading “Risk Factors” in the Company’s Annual Information Form, and under the heading “Risks and Uncertainties” in the MD&A. of the Company dated March 1, 2022, for the quarter ended December 31, 2021, filed under the Company’s profile on SEDAR at www.sedar.com.
Neither the TSX-V nor its Regulation Services Provider (as that term is defined in the policies of the TSX-V) accepts responsibility for the adequacy or accuracy of this release.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/116338